Akèy › Artrit Rematoid › Pennsylvania
Etid klinik pou Artrit Rematoid nan Pennsylvania
10 etid pou Artrit Rematoid ap chèche patisipan nan sit nan Pennsylvania.
Vil nan Pennsylvania
Tèks ofisyèl etid la (Anglè)
RA-PRO PRAGMATIC TRIAL
- Altoona Center for Clinical Research, Duncansville
- Rheumatology and Arthritis Care Center, Exton
- Allegheny Health Network, Pittsburgh
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT04692493Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
- Local Institution - 0071, Philadelphia
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Sep 22, 2026 · NCT07412704A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
- Altoona Center For Clinical Research /ID# 272479, Duncansville
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06972446A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
- Altoona Center For Clinical Research, Duncansville
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07137598Phase 1b/2 Study of IV Sarilumab in Adult With RA
- Altoona Center for Clinical Research - Duncansville- Site Number : 8400007, Duncansville
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT07704580R-2487 in Patients With Rheumatoid Arthritis
- Altoona Center for Research, Duncansville
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Jun 12, 2026 · NCT05961592Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Ap rekriteEtid obsèvasyon
2 Months – 60 Years · Tout sèks · Mizajou Jan 13, 2026 · NCT04528355A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
- Altoona Center for Clinical Research, Duncansville
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 6, 2025 · NCT06671054ConsideRAte Study - Splenic Stimulation for RA
- Altoona Center for Clinical Research, Altoona
Ap rekrite
Laj 22 a 75 · Tout sèks · Mizajou May 22, 2024 · NCT05003310Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.